Seeing the Light: Improving Diabetic Retinopathy Outcomes by Bringing Screening to the Dialysis Clinic
- PMID: 36245657
- PMCID: PMC9528370
- DOI: 10.34067/KID.0003752022
Seeing the Light: Improving Diabetic Retinopathy Outcomes by Bringing Screening to the Dialysis Clinic
Keywords: diabetes; diabetes and the kidney; diabetic retinopathy; dialysis; glycemia; kidney failure.
Conflict of interest statement
In the last 3 years, J. Flythe has received speaking honoraria from the American Society of Nephrology and multiple universities and investigator-initiated research funding unrelated to this project from the Renal Research Institute, a subsidiary of Fresenius Kidney Care, North America. She serves on a medical advisory board for Fresenius Kidney Care, North America, and a scientific advisory board and Data and Safety Monitoring Committee for the NIDDK. She has received consulting fees from Fresenius Kidney Care, North America, and AstraZeneca. K. Klein has nothing to disclose.
Comment on
-
The Integration of Diabetic Eye Screening into Hemodialysis Units in Northern Ireland.Kidney360. 2022 May 18;3(9):1542-1544. doi: 10.34067/KID.0001802022. eCollection 2022 Sep 29. Kidney360. 2022. PMID: 36245648 Free PMC article.
References
-
- Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, Bikbov MM, Wang YX, Tang Y, Lu Y, Wong IY, Ting DSW, Tan GSW, Jonas JB, Sabanayagam C, Wong TY, Cheng C-Y: Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology 128: 1580–1591, 2021. 10.1016/j.ophtha.2021.04.027 - DOI - PubMed
-
- International Diabetes Federation : IDF Diabetes Atlas, 10th Ed., Brussels, Belgium, International Diabetes Federation, 2021
-
- United States Renal Data System : USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Available at: https://adr.usrds.org/2021/end-stage-renal-disease. Accessed June 20, 2022
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
